Alice's oversexed sister, Edith, also on board and betrothed to a Spanish ex-prince, will eventually sleep with Bruno, the blind head hijacker, seizing a chance to prove that she hasn't lost her zing.
Hold the blind head rail up to the window in the position where you plan for it go be mounted (inside, outside or ceiling).
A blind, head-to-head comparison study of SpinDx versus the gold-standard mouse bioassay demonstrates 100-fold improvement in sensitivity (limit of detection = 0.09 pg/mL), while achieving total sample-to-answer time of <30 min with 2-μL required volume of the unprocessed sample.
Snap the blinds head rail into the brackets by hooking the front end into the clip and then lifting the back end until it clicks into place.
At the same time, it's difficult to read the description of an alien face as "a placenta with two foetuses – maybe three-month-old twins, hairless and blind – nestled head to head, knee to knee", or an energy-saving lightbulb as "a segment of radioactive intestine suspended from a wire", without remembering the hallucinatory intensity of work such as Under the Skin.
The present analysis of data from a multicenter, randomized, double-blind, head-to-head study suggests that frovatriptan and rizatriptan are similarly effective in the immediate treatment of women with menstrually related migraine.
In conclusion, our multicenter, randomized, double-blind, head-to-head study suggests that frovatriptan and almotriptan are similarly preferred in patients with acute migraine attacks and have a similar antimigraine efficacy.
In conclusion, results of the present analysis of data from a multicenter, randomized, double-blind, head-to-head, cross-over study suggest that frovatriptan and almotriptan are similarly effective in the immediate treatment of acute attack of menstrually related migraine.
There is some evidence that an AED whose primary mechanism of action does not involve blockade of voltage-dependent sodium channels may do less well than carbamazepine in terms of efficacy end-points in a double-blind, head-to-head comparison.
Given the absence of data from double-blind, head-to-head trials, it is not currently possible to conclude that any formulation is superior to another.
Unfortunately, there are no published double-blind, head-to-head studies from which to draw further conclusions on the clinical differences between and patient preferences for the currently available formulations.
